Blood Pressure Medication Recalled For Cancer-Causing Substance

Posted by

Macleods Pharmaceuticals Limited has recalled a lot of Losartan Potassium/Hydrochlorothiazide combination tablets due to the fact that they may contain a cancer-causing substance.

According to the  U.S. Food and Drug Administration, the tablets contained small amounts of N-nitrosodiethylamine (NDEA) and has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC) classification.

The tablets that have been recalled are listed below.

NDC Manufacturer Product Description Lot/Batch Expiration Date
33342-0052-10 Macleods Pharmaceuticals Limited Losartan Potassium/ Hydrochlorothiazide combination tablets 100mg/25mg, 90 count bottles BLM715A Jul -201

The FDA advises consumers to “contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.”

For general questions regarding the return of this product should contact Qualanex via email at or call 888-280-2042 (7:00 am to 4:00 pm CST Monday -Friday).

Related Posts

Show more ↓